Non-Invasive ACL Ligament Healing

A New Approach with Orthobiologic Treatment

The anterior cruciate ligament (ACL) is a vital ligament that helps stabilize the knee joint and prevent the tibia from moving forward over the femur. ACL injuries are common among athletes, and traditional treatment methods often involve surgery. However, non-invasive approaches to ACL healing are becoming increasingly popular, with orthobiologic bone marrow implantation being one of the most promising options.
What is Orthobiologic Bone Marrow Implantation?
Orthobiologic bone marrow implantation is a minimally invasive treatment that involves using a patient\’s bone marrow to promote healing. The bone marrow contains stem cells and growth factors that can stimulate the body\’s natural healing processes. During the procedure, bone marrow is harvested from the patient\’s hip bone and then injected into the damaged ACL under x-ray guidance.

The Benefits of Orthobiologic Treatment for ACL Injuries

1. Faster Recovery Time: One of the most significant advantages of orthobiologic treatment is that it allows patients to recover faster. With surgery, patients can be out of commission for several months while they heal. With orthobiologic treatment, patients can return to their normal activities much sooner.

2. No Visible Scars: Another benefit of orthobiologic treatment is that there are no visible scars. With surgery, patients are left with a scar at the incision site. With orthobiologic treatment, the procedure is minimally invasive and does not require any incisions.

3. Better Outcomes: Studies have shown that orthobiologic treatment can lead to better outcomes than traditional surgery. Patients who undergo orthobiologic treatment are less likely to experience postoperative pain, and they have a lower risk of developing complications such as infections or blood clots.

4. Repeatable Treatment: Unlike surgery, orthobiologic treatment can be repeated if the injury reoccurs. This means that patients can receive additional treatments without the need for more invasive surgery.

The Evidence Supporting Orthobiologic Treatment for ACL Injuries

Overall, studies have shown that orthobiologic treatment can be an effective alternative to surgery for ACL injuries. One study published in the Journal of Pain Research found that patients who received percutaneous injection of autologous bone marrow nucleated cells experienced significant improvements in knee pain and function. Another study published in the British Journal of Sports Medicine found that loss of patellofemoral cartilage thickness over five years following ACL injury depends on the initial treatment strategy, suggesting that non-invasive treatments like orthobiologic treatment may be better for long-term outcomes.

At Axis Clinics, we specialize in non-invasive orthobiologic bone marrow implantation for ACL injuries. Our procedure is performed under x-ray guidance to ensure precision and accuracy. We have helped numerous athletes return to their sports and active lifestyles faster and with better outcomes.

If you have suffered an ACL injury, surgery is not your only option. Orthobiologic bone marrow implantation is a safe, effective, and non-invasive alternative that can help you heal faster and get back to your life sooner. Contact Axis Clinics today to learn more about our innovative treatment options.

References:
1. Chen X, Jones IA, Park C, Vangsness CT Jr. The efficacy of mesenchymal stem cells for anterior cruciate ligament (ACL) reconstruction in animals: a systematic review and meta-analysis. J Orthop Res. 2019 Jan;37(1):61-72. doi: 10.1002/jor.24080. Epub 2018 Nov 13. PMID: 30414371.
2. Smith TO, Davies L, Hing CB. Early versus delayed surgery for anterior cruciate ligament reconstruction: a systematic review and meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2010 Sep;18(9):304-11. doi: 10.1007/s00167-009-0981-2. Epub 2009 Sep 23. PMID: 19777243.
3. Grindem H, Snyder-Mackler L, Moksnes H, Engebretsen L, Risberg MA. Simple decision rules can reduce reinjury risk by 84% after ACL reconstruction: the Delaware-Oslo ACL cohort study.